Psycheceutical Bioscience
Pre-clinicalDevelops psychedelic-based therapeutics for mental health disorders.
Founded
2019
Focus
Drug Delivery
About
Develops psychedelic-based therapeutics for mental health disorders.
Funding History
2Total raised: $10M
Series A$8MUndisclosedJan 15, 2022
Seed$2MUndisclosedMay 15, 2020
Company Info
TypePrivate
Founded2019
LocationMiami, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile